Condition: Estrogen Receptor Status - Clinical Trial Eligibility Criteria


rs3135718 in FGFR2 gene and Estrogen Receptor Status - Clinical Trial Eligibility Criteria PMID 27764800 2016 Strong association between the FGFR2 locus and ER status of breast cancer patients was observed (ER-positive n=6211, ER-negative n=2516; rs3135718 OR=1.34 p=5.46×10-12).

PMID 27764800 2016 GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.